SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000816284-19-000031
Filing Date
2019-04-25
Accepted
2019-04-25 17:09:43
Documents
103
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2019033110q.htm 10-Q 2249635
2 EXHIBIT 31.1 ex311certificationoftheceo.htm EX-31.1 11009
3 EXHIBIT 31.2 ex312certificationofthecfo.htm EX-31.2 12311
4 EXHIBIT 32.1 ex321certificationoftheceo.htm EX-32.1 6909
5 EXHIBIT 32.2 ex322certificationofthecfo.htm EX-32.2 8307
  Complete submission text file 0000816284-19-000031.txt   12130934

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT celg-20190331.xml EX-101.INS 3137523
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celg-20190331.xsd EX-101.SCH 76211
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT celg-20190331_cal.xml EX-101.CAL 130185
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celg-20190331_def.xml EX-101.DEF 412973
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celg-20190331_lab.xml EX-101.LAB 947388
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celg-20190331_pre.xml EX-101.PRE 607187
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34912 | Film No.: 19768335
SIC: 2834 Pharmaceutical Preparations